Clinical trial NCT04138316 - References

Migraine — CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study

Citation(s)

•   Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sandor PS; European Federation of Neurological Societies
  EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force. Eur J Neurol. 2009 Sep;16(9):968-81. doi: 10.1111/j.1468-1331.2009.02748.x.
•   Garcia-Azorin D, Santos-Lasaosa S, Gago-Veiga AB, Viguera Romero J, Guerrero-Peral AL
  Real world preventative drug management of migraine among Spanish neurologists. J Headache Pain. 2019 Feb 15;20(1):19. doi: 10.1186/s10194-019-0971-6.
•   GBD 2016 Neurology Collaborators
  Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 May;18(5):459-480. doi: 10.1016/S1474-4422(18)30499-X. Epub 2019 Mar 14.
•   GBD 2017 DALYs and HALE Collaborators
  Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3. Erratum In: Lancet. 2019 Jun 22;393(10190):e44.
•   Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
  Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202. No abstract available.
•   Pedraza MI, Mulero P, Ruiz M, de la Cruz C, Herrero S, Guerrero AL
  Characteristics of the first 2,000 patients registered in a specialist headache clinic. Neurologia. 2015 May;30(4):208-13. doi: 10.1016/j.nrl.2013.12.010. Epub 2014 Jan 30. English, Spanish.
•   Stovner LJ, Andree C
  Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain. 2010 Aug;11(4):289-99. doi: 10.1007/s10194-010-0217-0. Epub 2010 May 16.
•   Stovner LJ, Linde M, Gravdahl GB, Tronvik E, Aamodt AH, Sand T, Hagen K
  A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study. Cephalalgia. 2014 Jun;34(7):523-32. doi: 10.1177/0333102413515348. Epub 2013 Dec 11.
•   Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G
  Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA. 2003 Jan 1;289(1):65-9. doi: 10.1001/jama.289.1.65.

CandeSpartan Study Candesartan Spanish Response-prediction and Tolerability Study Observational Study on Response Predictors and Tolerability of Candesartan in Usual Clinical Practice

Details for clinical trial NCT04138316